TY  - CONF 
AU  - Valladares Ayerbes, Manuel
AU  - López López, Rafael
AU  - Salgado Fernández, Mercedes
PY  - 2015
SN  - 0923-7534
UR  - http://hdl.handle.net/20.500.11940/1478
LA  - eng
TI  - Phase II study of Regorafenib as single agent for the treatment of patients with metastatic colorectal cancer with any RAS or BRAF mutation and previously treated with FOLFOXIRI plus bevacizumab
DO  - 10.1093/annonc/mdv233.269
VL  - 26
ER  -